Seattle Genetics

In the News

02/03/2010	Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma
02/02/2010	Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2009 Financial Results on February 9, 2010

Webcasts and Events

Event:	RBC Capital Markets Healthcare Conference
Date:	03/03/2010
Time:	12:00 PM

Event:	Fourth Quarter and Year 2009 Earnings Conference Call
Date:	02/09/2010
Time:	02:00 PM